Psychedelics VC fund Iter Investments has recently closed its last round of Fund I with over $20 million committed, a successful outcome considering the targeted raise in their first fund launch in April 2021, and an indication of investor interest in the psychedelics market.
Iter’s team includes experts and professionals within the space representing the end-to-end psychedelic value chain, which enables investment opportunity sourcing, diligence and portfolio management.
